Literature DB >> 16801301

Attitudes and knowledge about nicotine and nicotine replacement therapy.

Marc E Mooney1, Adam M Leventhal, Dorothy K Hatsukami.   

Abstract

Nicotine replacement therapies (NRTs) represent an effective means of promoting smoking cessation, but they remain underutilized. Negative attitudes and false beliefs about nicotine and nicotine replacement may cause NRT underutilization. In a randomized, controlled, single-blind study of nicotine gum, 97 smokers were assessed on their attitudes and knowledge about nicotine, nicotine replacement, and smoking cessation therapy. Information from these self-report measures was used in an intervention that provided tailored, brief feedback to promote positive attitudes and accurate knowledge about NRT. Considerable variability in pretreatment attitudes and knowledge was observed across individuals. Moreover, attitudes and knowledge showed a consistent pattern of intercorrelation and were systematically related to smoking characteristics (e.g., prior use of NRT, nicotine dependence, treatment completion). The brief feedback intervention led to a significant global elevation in attitudes about nicotine, NRT, and assisted cessation but not knowledge about nicotine. Changes in attitudes and knowledge were not significantly related to gum use or smoking cessation. Recommendations for the appropriate application of brief feedback are offered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801301     DOI: 10.1080/14622200600670397

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  46 in total

1.  Design cues for tobacco communication: Heuristic interpretations and usability of online health information about harmful chemicals.

Authors:  Allison J Lazard
Journal:  Int J Med Inform       Date:  2020-05-17       Impact factor: 4.046

2.  The experimental tobacco marketplace: Narrative influence on electronic cigarette substitution.

Authors:  W Brady DeHart; Brent A Kaplan; Derek A Pope; Alexandra M Mellis; Warren K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  2018-11-05       Impact factor: 3.157

3.  Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers.

Authors:  Matthew J Carpenter; Anthony J Alberg; Kevin M Gray; Michael E Saladin
Journal:  Clin Trials       Date:  2010-03-25       Impact factor: 2.486

4.  Use of tobacco cessation treatments among young adult smokers: 2005 National Health Interview Survey.

Authors:  Susan J Curry; Amy K Sporer; Oksana Pugach; Richard T Campbell; Sherry Emery
Journal:  Am J Public Health       Date:  2007-06-28       Impact factor: 9.308

5.  Educating smokers about their cigarettes and nicotine medications.

Authors:  Maansi Bansal-Travers; K Michael Cummings; Andrew Hyland; Anthony Brown; Paula Celestino
Journal:  Health Educ Res       Date:  2010-01-11

6.  Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers.

Authors:  Katherine K Ryan; Elizabeth Garrett-Mayer; Anthony J Alberg; Kathleen B Cartmell; Matthew J Carpenter
Journal:  Nicotine Tob Res       Date:  2011-04-04       Impact factor: 4.244

7.  Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks.

Authors:  Lauren R Pacek; F Joseph McClernon; Rachel L Denlinger-Apte; Melissa Mercincavage; Andrew A Strasser; Sarah S Dermody; Ryan Vandrey; Tracy T Smith; Natalie Nardone; Dorothy K Hatsukami; Joseph S Koopmeiners; Rachel V Kozink; Eric C Donny
Journal:  Tob Control       Date:  2017-07-22       Impact factor: 7.552

8.  Predictors of adherence to nicotine replacement therapy: Machine learning evidence that perceived need predicts medication use.

Authors:  Nayoung Kim; Danielle E McCarthy; Wei-Yin Loh; Jessica W Cook; Megan E Piper; Tanya R Schlam; Timothy B Baker
Journal:  Drug Alcohol Depend       Date:  2019-10-25       Impact factor: 4.492

9.  Perceived Health Risks of Snus and Medicinal Nicotine Products.

Authors:  Dorothy K Hatsukami; R I Vogel; Herb H Severson; Joni A Jensen; Richard J O'Connor
Journal:  Nicotine Tob Res       Date:  2015-09-18       Impact factor: 4.244

10.  Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.

Authors:  Theresa M Marteau; Marcus R Munafò; Paul Aveyard; Chloe Hill; Sophia Whitwell; Thomas A Willis; Rachel A Crockett; Gareth J Hollands; Elaine C Johnstone; Alison J Wright; A Toby Prevost; David Armstrong; Stephen Sutton; Ann Louise Kinmonth
Journal:  BMC Public Health       Date:  2010-11-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.